IL4 and gastric cancer: At the same time, in order to further explain the driving effect of IL-4 on immunotherapy resistance of gastric cancer, we further analyzed the Fold Change of cytokine levels in the two groups of patients, and found that the increase of IL-4 was the most significant (PD + SD/PR + CR, fold change = 3.79) (Fig. 1C).